.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Deloitte
McKesson
Covington
AstraZeneca
Medtronic
McKinsey
US Army
QuintilesIMS
Merck

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021902

« Back to Dashboard
NDA 021902 describes VEREGEN, which is a drug marketed by Medigene Ag and is included in one NDA. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the VEREGEN profile page.

The generic ingredient in VEREGEN is sinecatechins. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the sinecatechins profile page.

Summary for NDA: 021902

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Dermatological Agents

Suppliers and Packaging for NDA: 021902

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VEREGEN
sinecatechins
OINTMENT;TOPICAL 021902 NDA PharmaDerm a division of Fougera Pharmaceuticals Inc. 10337-450 10337-450-03 1 TUBE in 1 CARTON (10337-450-03) > 30 g in 1 TUBE
VEREGEN
sinecatechins
OINTMENT;TOPICAL 021902 NDA PharmaDerm a division of Fougera Pharmaceuticals Inc. 10337-450 10337-450-08 1 TUBE in 1 CARTON (10337-450-08) > 2 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength15%
Approval Date:Oct 31, 2006TE:RLD:Yes
Patent:5,795,911Patent Expiration:Oct 31, 2020Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF GENITAL WARTS
Patent:5,968,973Patent Expiration:Apr 10, 2017Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF GENITAL WARTS
Patent:7,858,662Patent Expiration:Oct 2, 2026Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF GENITAL WARTS

Expired Orange Book Patents for NDA: 021902

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medigene Ag
VEREGEN
sinecatechins
OINTMENT;TOPICAL021902-001Oct 31, 20065,968,973► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Citi
Teva
Boehringer Ingelheim
UBS
Express Scripts
Harvard Business School
Cantor Fitzgerald
US Department of Justice
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot